Skip to content

The Effects of beta-blocker Use on Patients with Septic Shock: A Randomized Controlled Trial

The Effects of beta-blocker Use on Patients with Septic Shock: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007049
Enrollment
Unknown
Registered
2015-09-11
Start date
2015-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock

Interventions

experimental :esmolol
control :isotonic line

Sponsors

the First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria are the presence of septic shock requiring norepinephrine to maintain a mean arterial pressure (MAP) of 65mm Hg or higher despite appropriate volume resuscitation (PAOP>=12mmHg CVP>=8mmHg), a heart rate of 95/min or higher.

Exclusion criteria

Exclusion criteria: 1. Younger than 18 years; 2. beta-blocker therapy prior to randomization; 3. Presence of pronounced cardiac dysfunction; 4. significant valvular heart disease; 5. pregnancy suckling; 6. Presence of severe basic diseases, such as AIDS, terminal maligant cancer, which probably be the main cause of death.

Design outcomes

Primary

MeasureTime frame
twenty-eight day mortality;

Secondary

MeasureTime frame
heart rate;90-day mortality;norepinephrine requirements;

Countries

China

Contacts

Public ContactTongwen Sun
suntongwen@163.com+86 13838516916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026